Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gestional Trophoblastic Neoplasia Ultrasound Assessment: Titanium Study

NCT06284980 is registered in ClinicalTrials.gov with Fondazione Policlinico Universitario Agostino Gemelli IRCCS as lead sponsor.

NCT NCT06284980
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06284980 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gestional Trophoblastic Neoplasia Ultrasound Assessment: Titanium Study
Lead sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase
Observational
Overall status
Unknown status
Start date
January 24, 2019
Completion date
December 31, 2025
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

describe typical gray scale/color doppler ultrasound features of gestational trophoblastic neoplasia at the us examination, to assess if there are differences at the baseline us scan between low-risk and high-risk patients, to identify ultrasound predictors of resistance to first-line single drug chemotherapy in low-risk gtn patients, to investigate if machine learning (ml) algorithms (radiomics, deep neural networks (dnn), and other machine learning algorithms